Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.Ingmar Wolff, Cristiana Sessa, Y. Groot et al.|PubMed|1996Cited by 16
Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus scheduleAhmad Awada, D. J. Th. Wagener, Cornelis J. A. Punt et al.|British Journal of Cancer|1999Cited by 16
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I studyOlaf van Tellingen, Jos H. Beijnen, W J Nooijen et al.|Cancer Chemotherapy and Pharmacology|1998Cited by 11